Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Ciprofibrate on Myocardial Insulin Sensitivity in Pre-diabetes
NCT03662984Phase 3Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Nov 2018
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ciprofibrate in Impaired glucose metabolism (IGM), sponsored by Maastricht University Medical Center+. Started Nov 2018; status: completed.
02
Drugs
ciprofibrate
03
Conditions
Impaired glucose metabolism (IGM)
Beyond the preview
Go deeper on NCT03662984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03662984.